Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Operating Expenses | 2,506 | 4,110 | 6,094 | 4,933 | 4,809 |
Operating Income | -2,506 | -4,110 | -6,094 | -4,933 | -4,809 |
Other Income | 37 | 40 | 47 | 51 | 57 |
Pre-tax Income | -2,469 | -4,070 | -6,047 | -4,882 | -4,752 |
Net Income Continuous | -2,469 | -4,070 | -6,047 | -4,882 | -4,752 |
Net Income | $-2,469 | $-4,070 | $-6,047 | $-4,882 | $-4,752 |
EPS Basic Total Ops | -6.24 | -11.04 | -17.65 | -14.77 | -14.41 |
EPS Basic Continuous Ops | -6.30 | -11.06 | -17.76 | -14.73 | -14.46 |
EPS Diluted Total Ops | -6.24 | -11.04 | -17.65 | -14.77 | -14.41 |
EPS Diluted Continuous Ops | -6.30 | -11.06 | -17.76 | -14.73 | -14.46 |
EBITDA(a) | $-2,505 | $-4,109 | $-6,092 | $-4,931 | $-4,807 |